drugset / Trial / NCT06645509

Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy

NCT06645509 ↗

Phase 2 Terminated 58 enrolled Dryox Health
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to assess the efficacy and safety of Victorhy, a topical TTB gel in patients with severe primary hand hyperhidrosis.

Timeline

Start
2024-04-29
Primary completion
2025-06-02
Completion
2025-06-02

Outcome

Outcome not reported

Stopped (Enrollment): “The trial was early terminated due to a slower patient accrual than expected. By the expiration date of the IMP batch manufactured for the trial (30 May 2025), only 58 patients were enrolled, below the planned N of 60.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Victorhy Unknown — Topical